Skip to main content

Table 2

From: Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction

Subject

Sex

Baseline NYHA Heart Failure Class

BASELINE

12 MONTHS

   

Myocardial T2* (ms)

LVEF (%)

Myocardial T2* (ms)

LVEF (%)

1

F

I

5.2

59

6.2

70

2

M

I

6.0

28

6.4

57

3

M

I

6.5

50

10.0

68

4

M

I

6.4

42

9.2

63

5

M

II

5.6

30

6.1

47

6

M

I

5.0

57

5.4

73

7

F

I

4.8

60

5.5

74

8

F

III

5.3

43

7.6

67

9

F

I

5.0

54

8.1

67

10

M

I

5.7

58

6.6

67

11

F

I

5.4

49

10.4

66

12

F

I

7.3

61

11.5

70

13

F

I

3.7

61

4.8

61

14

F

I

7.4

60

13.2

65

15

F

I

6.1

56

7.1

69